Get the app
NSEHealthcare

Mangalam Drugs And Organics Limited (MANGALAM)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹31.97-0.03%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹57 cr
Revenue YoY
-0.2%
Net profit
₹-8 cr
EPS
₹3.78
EPS estimate
₹4.50
Net margin
-13.4%

EPS came in at 3.78 against a street estimate of 4.50 — a miss of 16.0%.

Key statistics

Market cap
₹51 cr
Forward P/E
0.0
P/B
0.52
Book value
₹65.12
EPS (TTM)
₹-24.16
52-week high
₹77.60
52-week low
₹22.80
50-day MA
₹28.91
200-day MA
₹30.47
Beta
0.30

Shareholding

Promoters
37.69%

Recent filings & reports

DocumentDate
Annual report FY2026
MANGALAM DRUGS AND ORGANICS LIMITED - ANNUAL REPORT FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹23,213.27 lakhs (down from ₹31,7
2026-08-31
Quarterly results · Q1 FY27
MANGALAM DRUGS AND ORGANICS LIMITED – Q1 FY2026-27 SUMMARY HEADLINE NUMBERS • Revenue from Operations (Q1 FY27): Rs 5,711.93 lakhs (standalone), dow
2026-08-12
Quarterly results · Q4 FY26
MANGALAM DRUGS AND ORGANICS LIMITED - FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY 2025-26): Rs 23,213.27 lakhs vs Rs 31,757.60
2026-05-14
Quarterly results · Q3 FY26
MANGALAM DRUGS AND ORGANICS LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q3 FY2026 (Quarter ended 31 Dec 2025) – Consolidated: - Revenue from ope
2026-01-15
Quarterly results · Q2 FY26
MANGALAM DRUGS AND ORGANICS LIMITED – SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q2 FY2025-26 (Sept 30, 2025) Standalone Results: - Revenue f
2025-11-20
Quarterly results2025-11-13
Annual report FY2025
MANGALAM DRUGS & ORGANICS LIMITED – ANNUAL REPORT 2024-25 Summary for Retail Investors --- HEADLINE NUMBERS • Revenue from Operations (Standalone):
2025-09-10
Annual report FY2025
MANGALAM DRUGS & ORGANICS LIMITED - ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Revenue from Operations (Standalone): Rs. 31,757.60 lakhs (FY 2
2025-09-07

Readable in the app.

Deals & corporate news

AnnouncementDate
Bagging and receiving of new orders/contracts
Mangalam Drugs And Organics Limited has informed the Exchange about Bagging/Receiving of orders/contracts
2025-11-25
Amalgamation/Merger announcement by company with another entity
Mangalam Drugs And Organics Limited has informed the Exchange about Amalgamation/Merger
2025-10-15

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Mangalam Drugs And Organics Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.